Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Vivos Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 23 | 20 | −3 |
| Shares | 686.7K | 658.1K | −28.6K (−4.2%) |
| Value | $2.13M | $1.34M | −$793.2K (−37.3%) |
New holders (1)
Institutions that held Vivos Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acorn Wealth Advisors, LLC | 14,776 | $30.0K | 0.01% |
Sold out (4)
Institutions that held Vivos Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Connective Capital Management, LLC | 200,000 | $620.0K |
| Strategic Wealth Designers | 100,000 | $310.0K |
| Renaissance Technologies LLC | 39,279 | $121.8K |
| FMR LLC | 40 | $124 |